FENIL-DIHIDROBENZOFURANOS
LOS COMPUESTOS DE FORMULA (I), DONDE R1, R2, R3 Y R4 Y R5 TIENEN LOS SIGNIFICADOS CITADOS EN LA MEMORIA DESCRIPTIVA, SON AGENTES NUEVOS Y POTENTES INHIBIDORES DE LA PDE. PCT No. PCT/EP96/02031 Sec. 371 Date Nov. 18, 1997 Sec. 102(e) Date Nov. 18, 1997 PCT Filed May 11, 1996 PCT Pub. No. WO96/36625 P...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BAR, THOMAS MARTIN, THOMAS THIBAUT, ULRICH AMSCHLER, HERMANN GUTTERER, BEATE FLOCKERZI, DIETER |
| description | LOS COMPUESTOS DE FORMULA (I), DONDE R1, R2, R3 Y R4 Y R5 TIENEN LOS SIGNIFICADOS CITADOS EN LA MEMORIA DESCRIPTIVA, SON AGENTES NUEVOS Y POTENTES INHIBIDORES DE LA PDE.
PCT No. PCT/EP96/02031 Sec. 371 Date Nov. 18, 1997 Sec. 102(e) Date Nov. 18, 1997 PCT Filed May 11, 1996 PCT Pub. No. WO96/36625 PCT Pub. Date Nov. 21, 1996Compounds of formula I are selective cyclic nucleotide phosphodiesterase (PDE) inhibitors (namely of type IV). They and pharmaceutical compositions in which they are active ingredients are useful as bronchial therapeutics, for elimination of erectile dysfunction and for treatment of disorders, particularly those of inflammatory nature. The compounds are distinguished by low toxicity, good enteral absorption (high bioavailability), a great therapeutic breadth and the absence of significant side effects. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2191754TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2191754TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2191754TT33</originalsourceid><addsrcrecordid>eNrjZJB0c_Xz9NF18fTwdAnyd3L1i_J3Cw1y9PMP5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8a7BRoaWhuamJiEhxsbEqAEANYogtg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FENIL-DIHIDROBENZOFURANOS</title><source>esp@cenet</source><creator>BAR, THOMAS ; MARTIN, THOMAS ; THIBAUT, ULRICH ; AMSCHLER, HERMANN ; GUTTERER, BEATE ; FLOCKERZI, DIETER</creator><creatorcontrib>BAR, THOMAS ; MARTIN, THOMAS ; THIBAUT, ULRICH ; AMSCHLER, HERMANN ; GUTTERER, BEATE ; FLOCKERZI, DIETER</creatorcontrib><description>LOS COMPUESTOS DE FORMULA (I), DONDE R1, R2, R3 Y R4 Y R5 TIENEN LOS SIGNIFICADOS CITADOS EN LA MEMORIA DESCRIPTIVA, SON AGENTES NUEVOS Y POTENTES INHIBIDORES DE LA PDE.
PCT No. PCT/EP96/02031 Sec. 371 Date Nov. 18, 1997 Sec. 102(e) Date Nov. 18, 1997 PCT Filed May 11, 1996 PCT Pub. No. WO96/36625 PCT Pub. Date Nov. 21, 1996Compounds of formula I are selective cyclic nucleotide phosphodiesterase (PDE) inhibitors (namely of type IV). They and pharmaceutical compositions in which they are active ingredients are useful as bronchial therapeutics, for elimination of erectile dysfunction and for treatment of disorders, particularly those of inflammatory nature. The compounds are distinguished by low toxicity, good enteral absorption (high bioavailability), a great therapeutic breadth and the absence of significant side effects.</description><edition>7</edition><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030916&DB=EPODOC&CC=ES&NR=2191754T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030916&DB=EPODOC&CC=ES&NR=2191754T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BAR, THOMAS</creatorcontrib><creatorcontrib>MARTIN, THOMAS</creatorcontrib><creatorcontrib>THIBAUT, ULRICH</creatorcontrib><creatorcontrib>AMSCHLER, HERMANN</creatorcontrib><creatorcontrib>GUTTERER, BEATE</creatorcontrib><creatorcontrib>FLOCKERZI, DIETER</creatorcontrib><title>FENIL-DIHIDROBENZOFURANOS</title><description>LOS COMPUESTOS DE FORMULA (I), DONDE R1, R2, R3 Y R4 Y R5 TIENEN LOS SIGNIFICADOS CITADOS EN LA MEMORIA DESCRIPTIVA, SON AGENTES NUEVOS Y POTENTES INHIBIDORES DE LA PDE.
PCT No. PCT/EP96/02031 Sec. 371 Date Nov. 18, 1997 Sec. 102(e) Date Nov. 18, 1997 PCT Filed May 11, 1996 PCT Pub. No. WO96/36625 PCT Pub. Date Nov. 21, 1996Compounds of formula I are selective cyclic nucleotide phosphodiesterase (PDE) inhibitors (namely of type IV). They and pharmaceutical compositions in which they are active ingredients are useful as bronchial therapeutics, for elimination of erectile dysfunction and for treatment of disorders, particularly those of inflammatory nature. The compounds are distinguished by low toxicity, good enteral absorption (high bioavailability), a great therapeutic breadth and the absence of significant side effects.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB0c_Xz9NF18fTwdAnyd3L1i_J3Cw1y9PMP5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8a7BRoaWhuamJiEhxsbEqAEANYogtg</recordid><startdate>20030916</startdate><enddate>20030916</enddate><creator>BAR, THOMAS</creator><creator>MARTIN, THOMAS</creator><creator>THIBAUT, ULRICH</creator><creator>AMSCHLER, HERMANN</creator><creator>GUTTERER, BEATE</creator><creator>FLOCKERZI, DIETER</creator><scope>EVB</scope></search><sort><creationdate>20030916</creationdate><title>FENIL-DIHIDROBENZOFURANOS</title><author>BAR, THOMAS ; MARTIN, THOMAS ; THIBAUT, ULRICH ; AMSCHLER, HERMANN ; GUTTERER, BEATE ; FLOCKERZI, DIETER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2191754TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2003</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BAR, THOMAS</creatorcontrib><creatorcontrib>MARTIN, THOMAS</creatorcontrib><creatorcontrib>THIBAUT, ULRICH</creatorcontrib><creatorcontrib>AMSCHLER, HERMANN</creatorcontrib><creatorcontrib>GUTTERER, BEATE</creatorcontrib><creatorcontrib>FLOCKERZI, DIETER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BAR, THOMAS</au><au>MARTIN, THOMAS</au><au>THIBAUT, ULRICH</au><au>AMSCHLER, HERMANN</au><au>GUTTERER, BEATE</au><au>FLOCKERZI, DIETER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FENIL-DIHIDROBENZOFURANOS</title><date>2003-09-16</date><risdate>2003</risdate><abstract>LOS COMPUESTOS DE FORMULA (I), DONDE R1, R2, R3 Y R4 Y R5 TIENEN LOS SIGNIFICADOS CITADOS EN LA MEMORIA DESCRIPTIVA, SON AGENTES NUEVOS Y POTENTES INHIBIDORES DE LA PDE.
PCT No. PCT/EP96/02031 Sec. 371 Date Nov. 18, 1997 Sec. 102(e) Date Nov. 18, 1997 PCT Filed May 11, 1996 PCT Pub. No. WO96/36625 PCT Pub. Date Nov. 21, 1996Compounds of formula I are selective cyclic nucleotide phosphodiesterase (PDE) inhibitors (namely of type IV). They and pharmaceutical compositions in which they are active ingredients are useful as bronchial therapeutics, for elimination of erectile dysfunction and for treatment of disorders, particularly those of inflammatory nature. The compounds are distinguished by low toxicity, good enteral absorption (high bioavailability), a great therapeutic breadth and the absence of significant side effects.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2191754TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | FENIL-DIHIDROBENZOFURANOS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A52%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BAR,%20THOMAS&rft.date=2003-09-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2191754TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |